EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseOpen Access

Risk of fracture with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: an updated meta-analysis of randomized controlled trials

Mahdieh Khoshzaban Banisi, Ehsan Emami, Mahdiyeh Nozad Varjovi, Alireza Shayesteh Kia, Mahtab Rasaiyan, Shayan Agha Amini Fashami, Niloofar Shirazi, Elahe Ahsan, Niloofar Deravi, Mahdyieh Naziri, Roza Zarei, Niloufar Shabani

International Journal of Physiology, Pathophysiology and Pharmacology · 2025

DOI: 10.62347/egnk3393 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Physiology, Pathophysiology and Pharmacology, 2025. Verfasst von Mahdieh Khoshzaban Banisi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences Tehran, Iran. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Type 2 diabetes mellituscohort studiesdipeptidyl peptidase-4 inhibitorselderly patientsfracture risksodium-glucose cotransporter-2 inhibitors

Autor:innen und Institutionen

  • Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences Tehran, Iran.
  • Students Research Committee, School of Pharmacy, Tehran University of Medical Science Tehran, Iran.
  • Student Research Committee, Faculty of Pharmacy, Tabriz University of Medical Sciences Tabriz, Iran.
  • Student Research Committee, School of Medicine, Islamic Azad University, Tehran Medical Branch Sciences Tehran, Iran.
  • Student Research Committee, School of Pharmacy, Hamadan University of Medical Sciences Hamadan, Iran.
  • Student Research Committee, School of Medicine, Isfahan University of Medical Sciences Isfahan, Iran.

Zitieren

APA

Banisi, M. K., Emami, E., Varjovi, M. N., Kia, A. S., Rasaiyan, M., Fashami, S. A. A., Shirazi, N., Ahsan, E., Deravi, N., Naziri, M., Zarei, R., & Shabani, N. (2025). Risk of fracture with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: an updated meta-analysis of randomized controlled trials. International Journal of Physiology, Pathophysiology and Pharmacology. https://doi.org/10.62347/egnk3393

Vancouver

Banisi MK, Emami E, Varjovi MN, Kia AS, Rasaiyan M, Fashami SAA, et al. Risk of fracture with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: an updated meta-analysis of randomized controlled trials. International Journal of Physiology, Pathophysiology and Pharmacology. 2025. doi:10.62347/egnk3393

BibTeX
@article{Banisi2025,
  author = {Banisi, Mahdieh Khoshzaban and Emami, Ehsan and Varjovi, Mahdiyeh Nozad and Kia, Alireza Shayesteh and Rasaiyan, Mahtab and Fashami, Shayan Agha Amini and Shirazi, Niloofar and Ahsan, Elahe and Deravi, Niloofar and Naziri, Mahdyieh and Zarei, Roza and Shabani, Niloufar},
  title = {Risk of fracture with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: an updated meta-analysis of randomized controlled trials},
  journal = {International Journal of Physiology, Pathophysiology and Pharmacology},
  year = {2025},
  doi = {10.62347/egnk3393}
}
Kostenlos starten →